These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 6752956)
1. Rapid and effective conversion of 6-keto-prostaglandin F1 alpha to 6,15-diketo-13, 14-dihydro-prostaglandin F1 alpha-immunoreactive material in vivo. Förstermann U; Neufang B; Hertting G Prostaglandins Leukot Med; 1982 Sep; 9(3):277-84. PubMed ID: 6752956 [TBL] [Abstract][Full Text] [Related]
2. Formation and elimination of prostacyclin metabolites in the cat in vivo as determined by radioimmunoassay of unextracted plasma. Machleidt C; Förstermann U; Anhut H; Hertting G Eur J Pharmacol; 1981 Aug; 74(1):19-26. PubMed ID: 7032951 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of 6-ketoprostaglandin F1 alpha and prostacyclin to 6,15-diketo-13,14-dihydroprostaglandin F1 alpha-like material in cats and rabbits. Förstermann U; Neufang B; Hertting G Biochim Biophys Acta; 1982 Sep; 712(3):684-91. PubMed ID: 6751407 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of prostacyclin and 6-keto-prostaglandin F1 alpha in man. Rosenkranz B; Fischer C; Weimer KE; Frölich JC J Biol Chem; 1980 Nov; 255(21):10194-8. PubMed ID: 7000774 [TBL] [Abstract][Full Text] [Related]
5. Very low levels of 6-keto-prostaglandin F1 alpha in human plasma. Siess W; Dray F J Lab Clin Med; 1982 Mar; 99(3):388-98. PubMed ID: 7035588 [TBL] [Abstract][Full Text] [Related]
6. Release of prostacyclin into the coronary venous blood in patients with coronary arterial disease. Kaijser L; Nowak J; Patrono C; Wennmalm A Adv Myocardiol; 1983; 4():371-8. PubMed ID: 6344165 [TBL] [Abstract][Full Text] [Related]
7. 6-Keto prostaglandin F1 alpha, thromboxane B2 and 13,14-dihydro-15-keto prostaglandin F levels in maternal and fetal plasma. Yamaguchi M; Mori N Prostaglandins Leukot Med; 1984 Sep; 15(3):325-36. PubMed ID: 6593746 [TBL] [Abstract][Full Text] [Related]
8. Measurement of 6-keto-prostaglandin E1 alpha in human plasma with radioimmunoassay: effect of prostacyclin infusion. Ylikorkala D; Viinikka L Prostaglandins Med; 1981 Apr; 6(4):427-36. PubMed ID: 7025068 [TBL] [Abstract][Full Text] [Related]
9. Effects of norepinephrine infusion on systemic hemodynamics and plasma 6-keto-prostaglandin F1 alpha in normotensive subjects and patients with essential hypertension. Ishii M; Uehara Y; Hirata Y; Atarashi K; Ikeda T; Sugimoto T; Takeda T; Murao S Jpn Circ J; 1982 May; 46(5):494-502. PubMed ID: 7043017 [TBL] [Abstract][Full Text] [Related]
10. A radioimmunoassay for 6-keto-prostaglandin F1 alpha utilizing an antiserum against 6-methoxime-prostaglandin F1 alpha. Application to study renal in vitro synthesis of prostacyclin. Oliw E Prostaglandins; 1980 Feb; 19(2):271-84. PubMed ID: 6992225 [TBL] [Abstract][Full Text] [Related]
11. Application of an alpha-sidechain length-specific monoclonal antibody to immunoaffinity purification and enzyme immunoassay of 2,3-dinor-6-keto-prostaglandin F1 alpha from human urine. Hiramatsu M; Hayashi Y; Yamamoto S; Hayashi A; Sawada M; Hamanaka N; Yamashita K Prostaglandins Leukot Essent Fatty Acids; 1994 Feb; 50(2):69-79. PubMed ID: 8171070 [TBL] [Abstract][Full Text] [Related]
12. The role of the kidney in the metabolism of prostacyclin by the 15-hydroxyprostaglandin dehydrogenase pathway in vivo. Förstermann U; Neufang B Biochim Biophys Acta; 1984 May; 793(3):338-45. PubMed ID: 6370311 [TBL] [Abstract][Full Text] [Related]
13. Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. Balazy M; Brass EP; Gerber JG; Nies AS Prostaglandins; 1988 Oct; 36(4):421-30. PubMed ID: 3070630 [TBL] [Abstract][Full Text] [Related]
14. Plasma prostacyclin from birth to adolescence. Kääpä P; Viinikka L; Ylikorkala O Arch Dis Child; 1982 Jun; 57(6):459-61. PubMed ID: 7046649 [TBL] [Abstract][Full Text] [Related]
15. Measurement of human venous plasma prostacyclin and metabolites by radioimmunoassay: a reappraisal. Forder RA; Carey F Prostaglandins Leukot Med; 1983 Nov; 12(3):323-46. PubMed ID: 6361783 [TBL] [Abstract][Full Text] [Related]
16. Effect of fetal and maternal intravascular antipyrine infusion on maternal plasma prostaglandin concentrations in the pregnant sheep at 104 to 127 days' gestation. Pimentel G; Figueroa JP; Mitchell MD; Massmann A; Nathanielsz PW Am J Obstet Gynecol; 1986 Dec; 155(6):1181-5. PubMed ID: 3789031 [TBL] [Abstract][Full Text] [Related]
17. Isolation of prostacyclin from whole blood. Skrinska V; Lucas FV Prostaglandins; 1981 Sep; 22(3):365-75. PubMed ID: 7029655 [TBL] [Abstract][Full Text] [Related]
18. Different results of plasma 6-keto-prostaglandin F1 alpha measurements utilizing two antisera with apparently similar specificity. Viinikka L; Ylikorkala O Prostaglandins Leukot Med; 1982 Jul; 9(1):1-7. PubMed ID: 6957891 [TBL] [Abstract][Full Text] [Related]
19. The effects of ritodrine on prostaglandin metabolite concentrations in the blood of pregnant baboons. Hankins GD; Strickland DM; Hauth JC; Kuehl TJ; Mitchell MD Arch Gynecol; 1983; 234(1):21-6. PubMed ID: 6362573 [TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects. Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]